No bio available.

Semi-retired; previously Foundation Prof/Director of Respiratory Medicine at Monash Uni/Alfred Hospital; Professor of Medicine at Uni Tasmania.

Associated Professor Serra Húnter, Deparment of Biomedicine, University of Barcelona, and Fundació Clinic Recerca Biomedica-IDIBAPS, Centro de Investigación Biomedica en Red Enfermedades Respiratorias, Spain

Christine is head of the Respiratory Group at The George Institute for Global Health; Clinical Professor at the University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney. She is a thoracic physician with a clinical research focus on the management of airways disease and has overseen many clinical trials and participated in international study steering committees and monitoring boards. Christine has been active in advocacy and leadership for lung health in Australia over many years. At The George Institute she manages a research group implementing trials in asthma and COPD in Australia, New Zealand and Asia.

Professor Shyamali Dharmage is a world-recognised leader in Life Course Epidemiology of Chronic Respiratory Diseases. She developed and leads the Allergy & Lung Health Unit, Centre for Epidemiology & Biostatistics, University of Melbourne and has been awarded the esteemed title of Redmond Barry Distinguished Professor and four prestigious Fellow titles (Thoracic Society of Australia and New Zealand, European Respiratory Society, College of Community Physicians of Sri Lanka, Dame Kate Campbell). Professor is in the top 0.018% among 219,873 all obstructive lung disease researchers worldwide (Expertscape). She has more than 500 publications and has been awarded >$75 million in grants. Prof Dharmage leads an internationally recognised research program and is the custodian and PI of two of the world’s key studies in allergies and lung health;including NHMRC funded Melbourne Atopy Cohort Study and Tasmanian Longitudinal Health Study. Her work in lung function trajectories has contributed substantially to the creation of the novel paradigm of pre-COPD. Her recognition of research excellence is evidenced by national and international advisory board invitations such as the Lancet Commissioner in COPD. This COPD Lancet commission provided a roadmap for elimination of COPD including proposing a novel COPD classification. She was also a member of the expert committee that developed the Australian COPD Blueprint and led its prevention chapter.